Skip to content

In the BioHarmony Drug Report Database


Amvaz, Dafiro, Exforge (amlodipine) is a small molecule pharmaceutical. Amlodipine was first approved as Amvaz on 2003-10-31. It is used to treat coronary artery disease, hypertension, and variant angina pectoris in the USA. It has been approved in Europe to treat hypertension. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D and voltage-dependent L-type calcium channel subunit alpha-1C.
Trade Name Dafiro HCT, Exforge HCT
Common Name Amlodipine
Indication coronary artery disease, hypertension, variant angina pectoris
Drug Class Phenylpyridine vasodilators (nifedipine type)
Get full access now